| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.50▼ | 0.51▼ | 0.51▼ | 0.45▲ | 0.48▲ |
| MA10 | 0.50▼ | 0.51▼ | 0.49▲ | 0.43▲ | 0.95▼ |
| MA20 | 0.51▼ | 0.48▲ | 0.47▲ | 0.46▲ | 1.21▼ |
| MA50 | 0.50▼ | 0.46▲ | 0.44▲ | 1.10▼ | 1.45▼ |
| MA100 | 0.48▲ | 0.44▲ | 0.45▲ | 1.23▼ | 3.62▼ |
| MA200 | 0.45▲ | 0.46▲ | 0.54▼ | 1.50▼ | 2.35▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.000▲ | 0.004▲ | 0.048▲ | -0.102▼ |
| RSI | 44.574▼ | 58.244▲ | 61.870▲ | 38.106▼ | 34.705▼ |
| STOCH | 26.581 | 64.985 | 83.015▲ | 55.270 | 2.516▼ |
| WILL %R | -77.835▼ | -30.751 | -30.751 | -24.155▲ | -94.906▼ |
| CCI | -139.880▼ | 22.229 | 66.024 | 129.221▲ | -78.837 |
|
Wednesday, February 11, 2026 07:33 AM
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina ...
|
|
Wednesday, February 11, 2026 06:02 AM
Outlook Therapeutics believes this determination is inconsistent with the totality of evidence submitted in the BLA, including data from an adequate and well-controlled study and confirmatory evidence ...
|
|
Wednesday, January 07, 2026 06:53 AM
Shares of Outlook Therapeutics OTLK have tumbled 66.5% in a week. The massive crash was observed after the FDA issued a third complete response letter (CRL) in late December, rejecting OTLK’s ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/02/26 | 0.4512 | 0.525 | 0.44 | 0.49 | 3,117,402 |
| 12/02/26 | 0.4804 | 0.487 | 0.4393 | 0.441 | 1,382,230 |
| 11/02/26 | 0.4351 | 0.4694 | 0.416 | 0.4694 | 2,180,725 |
| 10/02/26 | 0.4041 | 0.46 | 0.397 | 0.4209 | 1,730,802 |
| 09/02/26 | 0.4197 | 0.4288 | 0.395 | 0.4046 | 1,584,512 |
| 06/02/26 | 0.3991 | 0.443 | 0.3801 | 0.4294 | 1,204,175 |
| 05/02/26 | 0.3971 | 0.42 | 0.39 | 0.39 | 1,265,195 |
| 04/02/26 | 0.445 | 0.446 | 0.3971 | 0.40 | 1,659,494 |
| 03/02/26 | 0.44 | 0.4547 | 0.43 | 0.43 | 1,031,149 |
| 02/02/26 | 0.4302 | 0.4575 | 0.4206 | 0.44 | 836,564 |
|
|
||||
|
|
||||
|
|